Undruggable No More: AI Hits Disordered Proteins, Unlocks Therapy Targets
David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the human proteome.
Related Articles
RORing for oral tolerance
An antigen-presenting cell subtype tames the immune response to food antigens in early life
Large study of scientists who move their labs reveals how location drives productivity
Concentrating funding at high-powered universities can maximize output, paper argues, but may sacrifice broader benefits
Fearful of AI-generated grant proposals, NIH limits scientists to six applications per year
Some critics of the new policy say the cap could hinder researchers in need of funding
U.S. research community says new indirect cost model is still too complicated
Proposed changes to avert huge cuts in reimbursement get pushback at town hall
My academic job offer was rescinded. I’ll keep going—but U.S. researchers are running out of road
Despite an uncertain future, this postdoc will “keep doing the science I love while I still have a bench”
Why do some moms have more boys than girls—or vice versa? New study provides clues
Researchers find that certain genetic variants and mother’s age may have an impact on the sex of her children
Jura Bio’s AI Data Loop Enables Large-Scale De Novo Antibody Design
VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.
Scientists Supercharge Sugar Substitute – And It Starts Killing Cancer
Stevia, a zero-calorie sugar substitute, combined with probiotics, yields a surprising and targeted cancer-killing effect.
A new kind of telescope is set to search for mysterious fast radio bursts
Radio telescopes usually have giant dishes, but not these all-sky antenna arrays
Reimagining Health Education
How Cedars-Sinai’s Health Sciences University is training the next generation of healthcare leaders.
